Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liraglutide in type 1 diabetes: effects on glycemic control, counterregulation, and cognition during hypoglycaemia
2012-002526-67Phase 3Completed
- Sponsor
- Sten Madsbad
- Start
- Jul 2012
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 3 trial of liraglutide in diabetes mellitus type 1 (T1D), sponsored by Sten Madsbad. Primary endpoints: Effects on glycemic control, Effects on counterregulation during hypoglycaemia and 1 more. Started Jul 2012; status: completed.
02
Drugs
03
Conditions
diabetes mellitus type 1 (T1D)
Beyond the preview
Go deeper on 2012-002526-67.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-002526-67.